Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site.
Dubiella, C., Cui, H., Gersch, M., Brouwer, A.J., Sieber, S.A., Kruger, A., Liskamp, R.M., Groll, M.(2014) Angew.Chem.Int.Ed.Engl. 53: 11969-11973
- PubMed: 25244435 
- DOI: 10.1002/anie.201406964
- Primary Citation of Related Structures:  
- PubMed Abstract: 
The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood cancer and represents a promising strategy for modulating autoimmune diseases. In this study, we describe peptidic sulfonyl fluoride inhibitors that se ...